This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus

07 Dec 2012
Available as PDF in the following languages
This document is free of charge.

New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.

ECDC’s updated risk assessment concludes that there is still no evidence of sustained person-to-person transmission; the current facts still point towards a zoonotic or environmental source with occasional transmission to exposed humans.

© European Centre for Disease Prevention and Control (ECDC) 2005 - 2017